Back
KalVista Pharmaceuticals Vs. Haemonetics Industry Stock Comparison
Buy
56
KALV
KalVista Pharmaceuticals
Last Price:
11.91
Seasonality Move:
3.19%
Buy
60
HAE
Haemonetics
Last Price:
95.76
Seasonality Move:
7.07%
Buy
56
KalVista Pharmaceuticals (KALV)
is a Buy
Is KalVista Pharmaceuticals a Buy, Sell or Hold?
- The current KalVista Pharmaceuticals [KALV] share price is $11.92. The Score for KALV is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- KALV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Haemonetics (HAE)
is a Buy
Is Haemonetics a Buy, Sell or Hold?
- The current Haemonetics [HAE] share price is $95.73. The Score for HAE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- HAE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KALV Stock Price Chart
What is KalVista Pharmaceuticals's stock price today?
-
The KalVista Pharmaceuticals share price today is $11.92
The current trend is relatively stagnant and KALV is experiencing slight selling pressure.
HAE Stock Price Chart
What is Haemonetics's stock price today?
-
The Haemonetics share price today is $95.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HAE is experiencing buying pressure, which is a positive indicator for future bullish movement.
KALV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 50.6 | Buy |
| Chaikin Money Flow: | -14677 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.15 - 12.25) | Buy |
| Bollinger Bands (100): | (11.35 - 14.03) | Sell |
HAE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.01 | Buy |
| Relative Strength Index (14 RSI): | 64.66 | Buy |
| Chaikin Money Flow: | 191604 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.77 - 95.71) | Buy |
| Bollinger Bands (100): | (75.85 - 89.23) | Buy |
KALV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.09 | Sell |
| 20-day SMA: | 11.71 | Buy |
| 50-day SMA: | 11.79 | Buy |
| 200-day SMA: | 11.12 | Buy |
| 8-day EMA: | 12.04 | Sell |
| 20-day EMA: | 11.9 | Buy |
| 50-day EMA: | 11.98 | Sell |
| 200-day EMA: | 11.33 | Buy |
HAE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 95.29 | Buy |
| 20-day SMA: | 92.49 | Buy |
| 50-day SMA: | 86.19 | Buy |
| 200-day SMA: | 85.11 | Buy |
| 8-day EMA: | 95.25 | Buy |
| 20-day EMA: | 92.69 | Buy |
| 50-day EMA: | 87.94 | Buy |
| 200-day EMA: | 84.32 | Buy |
KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.40 per share, and an increase next year of $0.62 per share.
Haemonetics Earnings Growth & HAE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.98 per share, and an increase next year of $0.64 per share.
KalVista Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Haemonetics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||